Home » ‘Worrisome Deficiencies’ Noted in Warning to Polish Drugmaker
‘Worrisome Deficiencies’ Noted in Warning to Polish Drugmaker
The FDA has warned Polish pharmaceutical manufacturer Jelfa SA, citing “worrisome” cGMP deficiencies, including a number of repeat violations.
Drug GMP Report
Drug GMP Report
Upcoming Events
-
07May
-
14May
-
30May